(metronidazole) NL/H/36/001/DC Date 28 March 19 This module reflects the scientific discussion for the approval of Metronidazol Noridem 5 mg/ml, solution for infusion The procedure was finalised at 9 October 18 For information on changes after this date please refer to the 'steps taken after finalisation' at the end of this PAR A 43yearold man, who had tolerated spiramycin 2 years earlier, started receiving spiramycin/metronidazole Rhodogil;Hdowk3urgxfwv5hjxodwru\$xwkrulw\ 6hswhpehu &51 7/ 3djh ri 1$0(2)7(9(7(5,1$5
Spiramycin Metronidazole Active Ingredient Grovet Com
